- 25 years. One throughline.
Jennifer Snow.
“Health policy feels complex because it’s presented that way. It doesn’t have to be.”
EDUCATION
Georgetown University (Russian) → UNC Chapel Hill (Executive MPH)
CAREER PATH
Stanford → Avalere Health → CMS → AstraZeneca → Cencora, where she served as VP managing 25 people and a $10M service line.
Government.
Where I learned how policy gets made, and why it so often breaks down between intention and implementation.
Pharma.
Where I saw firsthand how coverage rules and reimbursement mechanics determine whether patients actually get access to treatments.
Consulting Leadership.
I ran a $10M practice with a team of 25, advising pharmaceutical companies, associations, and advocacy organizations on how to navigate all of it.
The pattern.
At every stage, I worked with smart, capable teams making high-stakes decisions without enough time to fully understand the policy landscape underneath them. Not because they lacked expertise — because the system is genuinely complex, it moves fast, and nobody’s job is to see the whole board.
That’s what I’ve spent 25 years doing. Telling teams which pieces actually matter for their business, their products, and their patients.
Employers & institutions
“I have had the pleasure of working with Jennifer Snow and Apteka for many years. Jennifer brings an exceptional level of expertise, professionalism, and genuine care to everything she does. Her depth of knowledge, strategic insight, attention to detail and ability to see issues from multiple perspectives has strengthened our ability to have a meaningful impact.”
— VP, Patient Group and Leader of National Coalition
- About Apteka
Translating pharmaceutical policy into strategy.
Most policy consultancies report what happened. Apteka translates what to do about it.
The firm works at the intersection of pharmaceutical policy and commercial strategy, helping manufacturers, patient and provider advocacy organizations, and emerging biotech turn regulatory complexity into confident decisions. The work spans Medicare, Medicaid, the IRA, 340B, PBM reform, and market access, but the through line is always the same: what does this mean for your products, your patients, and your strategy?
Apteka works with a deliberately small number of clients. That’s what makes the high-touch, direct-access model possible.
Policy,
to the point.
Actions
Socials
© 2026 Apteka. All rights reserved.
